Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From TeneoOne
Roche gives back choroideremia candidate to 4D Molecular after reviewing Phase I data, partners on synthetic GI therapy with Synlogic. AbbVie opts to acquire TeneoOne under 2019 agreement.
- Other Names / Subsidiaries
- TeneoBio, Inc.